AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2007
Aug 4, 2007
30786_dirs_2007-08-03_fe7a7765-ca3d-4b53-a567-9ef6dac2a91e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (bio,bio.b)
CIK: 0000012208
Period of Report: 2007-03-13
Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-03-13 | Bio-Rad A Common Stock | G | 350 | — | Disposed | 2033422 | Direct |
| 2007-03-13 | Bio-Rad B Common Stock | G | 2100 | — | Disposed | 259676 | Direct |
| 2007-08-01 | Bio-Rad B Common Stock | A | 1670 | — | Acquired | 261346 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-08-01 | Non-Qualified Stock Option (right to buy) | $75 | A | 5000 | Acquired | 2017-08-01 | Bio-Rad B Common Stock (5000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 34311 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 41176 | Indirect |
| Bio-Rad A Common Stock | 1140000 | Indirect |
Footnotes
F1: The shares are held by a limited partnership of which the reporting person is a general partner.
F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner.
F3: These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on 3/15/2007.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13